The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Vitiligo: interplay between oxidative stress and immune system
Abstract
Vitiligo is a multifactorial polygenic disorder with a complex pathogenesis, linked with both genetic and non‐genetic factors. The precise modus operandi for vitiligo pathogenesis has remained elusive. Theories regarding loss of melanocytes are based on autoimmune, cytotoxic, oxidant–antioxidant and neural mechanisms. Reactive oxygen species (ROS) in excess have been documented in active vitiligo skin. Numerous proteins in addition to tyrosinase are affected. It is possible that oxidative stress is one among the main principal causes of vitiligo. However, there also exists ample evidence for altered immunological processes in vitiligo, particularly in chronic and progressive conditions. Both innate and adaptive arms of the immune system appear to be involved as a primary event or as a secondary promotive consequence. There is speculation on the interplay, if any, between ROS and the immune system in the pathogenesis of vitiligo. The article focuses on the scientific evidences linking oxidative stress and immune system to vitiligo pathogenesis giving credence to a convergent terminal pathway of oxidative stress–autoimmunity‐mediated melanocyte loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of reactive oxygen species (ROS) in apoptosis induction
Simon, H.-U., Haj-Yehia, A., & Levi-Schaffer, F. (2000) · Apoptosis · doi:10.1023/a:1009616228304 · Cited by 2,774
Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their Families
Alkhateeb, A., Fain, P. R., Thody, A., Bennett, D. C., & Spritz, R. A. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00032.x · Cited by 728
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-141978 · Cited by 529
The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force
Taïeb, A., Picardo, M., & members, O. B. O. T. O. V. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00355.x · Cited by 517
Schallreuter, K. U., Moore, J., Wood, J. M., Beazley, W. D., Gaze, D. C., Tobin, D. J., Marshall, H. S., Panske, A., Panzig, E., & Hibberts, N. A. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640189 · Cited by 440
The Pigmentary System: Physiology and Pathophysiology
Hsin-Su, Y. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.4.478 · Cited by 429
Low Catalase Levels in the Epidermis of Patients with Vitiligo
Schallreuter, K. U., Wood, J. M., & Berger, J. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12492612 · Cited by 347
Maresca, V., Roccella, M., Roccella, F., Camera, E., Del Porto, G., Passi, S., Grammatico, P., & Picardo, M. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12335801 · Cited by 302
New Insights into the Pathogenesis of Vitiligo: Imbalance of Epidermal Cytokines at Sites of Lesions
Moretti, S., Spallanzani, A., Amato, L., Hautmann, G., Gallerani, I., Fabiani, M., & Fabbri, P. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.1o049.x · Cited by 301
A Critical Appraisal of Vitiligo Etiologic Theories. Is Melanocyte Loss a Melanocytorrhagy?
Gauthier, Y., Andre, M. C., & Taïeb, A. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00070.x · Cited by 299
Poole, I. C. L., van den Wijngaard, R. M., Westerhof, W., & Das, P. K. (1996) · Europe PMC (PubMed Central) · Cited by 282
Local Immune Response in Skin of Generalized Vitiligo Patients
van den Wijngaard, R., Wankowicz-Kalinska, A., Le Poole, C., Tigges, B., Westerhof, W., & Das, P. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780138 · Cited by 272
Swope, V. B., Abdel-Malek, Z., Kassem, L. M., & Nordlund, J. J. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12460991 · Cited by 269
Review of the etiopathomechanism of vitiligo: A convergence theory
Le Poole, I. C., Das, P. K., van den Wijngaard, R. M. J. G. J., Bos, J. D., & Westerhof, W. (1993) · Experimental Dermatology · doi:10.1111/j.1600-0625.1993.tb00023.x · Cited by 268
Wańkowicz-Kalińska, A., van den Wijngaard, R. M. J. G. J., Tigges, B. J., Westerhof, W., Ogg, G. S., Cerundolo, V., Storkus, W. J., & Das, P. K. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069521.42488.1b · Cited by 262
Jimbow, K., Chen, H., Park, J.-S., & Thomas, P. D. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.03952.x · Cited by 253
Vitiligo: Compendium of clinico-epidemiological features
Sehgal, V., & Srivastava, G. (2007) · Indian Journal of Dermatology, Venereology and Leprology · doi:10.4103/0378-6323.32708 · Cited by 250
The role of tyrosinase in autoimmune vitiligo
Song, Y.-H., Connor, E., Li, Y., Zorovich, B., Balducci, P., & Maclaren, N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91709-4 · Cited by 197
Oxidatively modified autoantigens in autoimmune diseases
Kurien, B. T., Hensley, K., Bachmann, M., & Scofield, R. H. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.020 · Cited by 186
Schallreuter, K. U., Elwary, S. M. A., Gibbons, N. C. J., Rokos, H., & Wood, J. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.082 · Cited by 182
Reduced skin homing by functional Treg in vitiligo: Absence of Treg in vitiligo skin
Klarquist, J., Denman, C. J., Hernandez, C., Wainwright, D. J., Strickland, F. M., Overbeck, A., Mehrotra, S., Nishimura, M. I., & Le Poole, I. C. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00688.x · Cited by 176
Bassiouny, D. A., & Shaker, O. (2011) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2010.03972.x · Cited by 176
Lili, Y., Yi, W., Ji, Y., Yue, S., Weimin, S., & Ming, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037513 · Cited by 176
Kroll, T. M., Bommiasamy, H., Boissy, R. E., Hernandez, C., Nickoloff, B. J., Mestril, R., & Caroline Le Poole, I. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23653.x · Cited by 175
Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo
Harning, R., Cui, J., & Bystryn, J.-C. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12492607 · Cited by 173
Genetic Association of the Catalase Gene (CAT) with Vitiligo Susceptibility
Casp, C. B., She, J., & Mccormack, W. T. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.00057.x · Cited by 172
The genetics of generalized vitiligo and associated autoimmune diseases
Spritz, R. A. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00384.x · Cited by 169
Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions
Wang, C. Q. F., Cruz-Inigo, A. E., Fuentes-Duculan, J., Moussai, D., Gulati, N., Sullivan-Whalen, M., Gilleaudeau, P., Cohen, J. A., & Krueger, J. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018907 · Cited by 169
Lang, K. S., Muhm, A., Moris, A., Stevanovic, S., Rammensee, H.-G., Caroli, C. C., Wernet, D., Schittek, B., Knauss-Scherwitz, E., & Garbe, C. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01363.x · Cited by 167
An immunohistological study of cutaneous lymphocytes in vitiligo
Badri, A. M. T. A., Todd, P. M., Garioch, J. J., Gudgeon, J. E., Stewart, D. G., & Goudie, R. B. (1993) · The Journal of Pathology · doi:10.1002/path.1711700209 · Cited by 165
Physiopathology and genetics of vitiligo
Passeron, T., & Ortonne, J.-P. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.10.001 · Cited by 163
Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo
Schallereuter, K. U., Wood, J. M., Ziegler, I., Lemke, K. R., Pittelkow, M. R., Lindsey, N. J., & Gütlich, M. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(94)90027-2 · Cited by 161
Autoimmune Etiology of Generalized Vitiligo
Le Poole, I. C., & Luiten, R. M. (2008) · Current Directions in Autoimmunity · doi:10.1159/000131485 · Cited by 160
Vitiligo puzzle: the pieces fall in place
Westerhof, W., & D’Ischia, M. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00399.x · Cited by 160
Ortonne, J., & Bose, S. K. (1993) · Pigment Cell Research · doi:10.1111/j.1600-0749.1993.tb00584.x · Cited by 158
Kotobuki, Y., Tanemura, A., Yang, L., Itoi, S., Wataya‐Kaneda, M., Murota, H., Fujimoto, M., Serada, S., Naka, T., & Katayama, I. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00945.x · Cited by 153
Jiménez‐Cervantes, C., Martinez‐Esparza, M., Pérez, C., Schneider‐Daum, N., Solano, F., & García-Borrón, J. C. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.12.2335 · Cited by 153
Hedstrand, H., Ekwall, O., Olsson, M. J., Landgren, E., Kemp, E. H., Weetman, A. P., Perheentupa, J., Husebye, E. S., Gustafsson, J., Betterle, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102391200 · Cited by 151
Oxidative Stress in Vitiligo: Photo-oxidation of Pterins Produces H2O2 and Pterin-6-carboxylic Acid
Rokos, H., Beazley, W. D., & Schallreuter, K. U. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6727 · Cited by 147
Koebner’s phenomenon in vitiligo: European position paper
van Geel, N., Speeckaert, R., Taïeb, A., Picardo, M., Böhm, M., Gawkrodger, D. J., Schallreuter, K. U., Bennett, D. C., van der Veen, W., Whitton, M. E., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00838.x · Cited by 147
Mitochondrial Impairment in Peripheral Blood Mononuclear Cells During the Active Phase of Vitiligo
Dell’Anna, M. L., Maresca, V., Briganti, S., Camera, E., Picardo, M., & Falchi, M. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01459.x · Cited by 143
The Genetics of Generalized Vitiligo
Spritz, R. A. (2008) · KARGER eBooks · doi:10.1159/000131501 · Cited by 135
Tyrosinase as an autoantigen in patients with vitiligo
Baharav, E., Merimski, O., Shoenfeld, Y., et al. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-727.x · Cited by 132
Rao, G. R., Rao, A. D., Moorthy, B., Rao, T., Sravani, P., Babu, N. K., & Gopal, K. V. T. (2009) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.48427 · Cited by 131
Okamoto, T., Fujii, S., Huang, S. K. S., Hoon, D. S. �., Irie, R. F., Nizze, A. J., & Morton, D. L. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00411.x · Cited by 130
Mechanisms of melanogenesis inhibition by tumor necrosis factor‐α in B16/F10 mouse melanoma cells
Martinez‐Esparza, M., Jiménez‐Cervantes, C., Solano, F., Lozano, J. A., & García-Borrón, J. C. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2550139.x · Cited by 124
Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo
Koca, R., Armutçu, F., Altinyazar, H. C., & Gurel, A. (2004) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2004.01524.x · Cited by 122
The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo
Kemp, E. H., Waterman, E. A., Hawes, B. E., O’Neill, K., Gottumukkala, R. V. S. R. K., Gawkrodger, D. J., Weetman, A. P., & Watson, P. F. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14643 · Cited by 120
Mandelcorn-Monson, R. L., Shear, N. H., Yau, E., Sambhara, S. R., Barber, B. H., Spaner, D., & Debenedette, M. A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12413.x · Cited by 115
Direct Evidence to Support the Role of Antigen-Specific CD8+ T Cells in Melanoma-Associated Vitiligo
Gal, F. L., Lefebvre, P., Deschemin, J., Andrieu, M., Guillet, J., Avril, M., Bosq, J., & Dore, M.-X. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01605.x · Cited by 113
Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo
Ahmed, M. B., Zarâa, I., Rekik, R., Elbeldi-Ferchiou, A., Kourda, N., Hmida, N. B., Abdeladhim, M., Karoui, O., Osman, A. B., Mokni, M., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00920.x · Cited by 109
Kemp, E. H., Waterman, Gawkrodger, et al. (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02503.x · Cited by 107
Laddha, N. C., Dwivedi, M., & Begum, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052298 · Cited by 107
Self-citationIn Vivo Destruction of Melanocytes by the IgG Fraction of Serum from Patients with Vitiligo
Gilhar, A., Zelickson, B. D., Ulman, Y., et al. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12324456 · Cited by 105
Yu, H.-S., Chang, K., Yu, C.-L., Li, H., Wu, M.-T., Wu, C.-S., & Wu, C. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12289743 · Cited by 104
The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo
Kemp, E. H., Waterman, E. A., Hawes, B. E., O’Neill, K., Gottumukkala, R. V. S. R. K., Gawkrodger, D. J., Weetman, A. P., & Watson, P. F. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214643 · Cited by 104
Spritz, R. A. (2010) · Genome Medicine · doi:10.1186/gm199 · Cited by 102
Study on the Antioxidant Status of Vitiligo Patients of Different Age Groups in Baroda
Agrawal, D. J., Shajil, E. M., Marfatia, Y., & Begum, R. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00149.x · Cited by 101
Self-citationThe Role of Oxidants and Antioxidants in Generalized Vitiligo
Yıldırım, M., Baysal, V., İnalöz, H. S., Kesici, D., & Delibaş, N. (2003) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2003.tb00356.x · Cited by 100
Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin
Schallreuter, K. U., & Pittelkow, M. (1988) · Archives of Dermatological Research · doi:10.1007/bf00456842 · Cited by 99
Increased monoamine oxidase A activity in the epidermis of patients with vitiligo
Schallreuter, K. U., Wood, J. M., Pittelkow, M. R., Büttner, G., Swanson, N. N., Körner, C., & Ehrke, C. (1996) · Archives of Dermatological Research · doi:10.1007/bf02505037 · Cited by 98
Bırol, A., Kısa, Ü., Kurtipek, G. S., Kara, F. K., Koçak, M. U., Erkek, E., & Çağlayan, O. (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2006.02744.x · Cited by 98
Kemp, E. H., Gawkrodger, D. J., MacNeil, S., Watson, P. F., & Weetman, A. P. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12276556 · Cited by 98
Chaudhri, G., Hunt, N. H., Clark, I. A., et al. (1988) · Cellular Immunology · doi:10.1016/0008-8749(88)90174-8 · Cited by 97
Serum selenium levels and blood glutathione peroxidase activities in vitiligo
Beazley, Gaze, D. C., Panske, Panzig, & Schallreuter (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02980.x · Cited by 93
Namazi, M. R. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00408.x · Cited by 89
Haznecı, E., Karabulut, A. B., Öztürk, Ç., Batçıoğlu, K., Doğan, G., Karaca, Ş., & Eşrefoğlu, M. (2005) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2004.02027.x · Cited by 88
Apoptosis of melanocytes in vitiligo results from antibody penetration
Ruı́z-Argüelles, A., Jimenez-Brito, G., Reyes-Izquierdo, P., Pérez‐Romano, B., & Sánchez-Sosa, S. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.07.012 · Cited by 87
Imran, M., Laddha, N. C., Dwivedi, M., Mansuri, M. S., Singh, J., Rani, R., Gokhale, R. S., Sharma, V., Marfatia, Y., & Begum, R. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11000.x · Cited by 85
Self-citationThe melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis
Cario, M., Pain, C., Gauthier, Y., & Taı̈eb, A. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00396.x · Cited by 84
van den Wijngaard, R. M., Aten, J., Scheepmaker, A., Poole, I. C. L., Tigges, A. J., Westerhof, W., & Das, P. K. (2000) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2000.03712.x · Cited by 84
Martinez‐Esparza, M., Jiménez‐Cervantes, C., Beermann, F., Aparício, P., Lozano, J. A., & García-Borrón, J. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.3967 · Cited by 76
Kemp, E. H., Gawkrodger, D. J., Watson, P. F., et al. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00746.x · Cited by 74
Salem, M. M. A. E. L., Shalbaf, M., Gibbons, N. C. J., Chavan, B., Thornton, M. J., & Schallreuter, K. U. (2009) · The FASEB Journal · doi:10.1096/fj.09-132621 · Cited by 74
Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo
Kemp, E. H., Emhemad, S., Akhtar, S., Watson, P. F., Gawkrodger, D. J., & Weetman, A. P. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01181.x · Cited by 73
HLA Alleles and Amino-Acid Signatures of the Peptide-Binding Pockets of HLA Molecules in Vitiligo
Singh, A. K., Sharma, P., Kar, H. K., Sharma, V., Tembhre, M. K., Gupta, S., Laddha, N. C., Dwivedi, M., Begum, R., Gokhale, R. S., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.240 · Cited by 72
Self-citationDefective calcium transport in vitiliginous melanocytes
Schallreuter-Wood, K. U., Pittelkow, M. R., & Swanson, N. N. (1996) · Archives of Dermatological Research · doi:10.1007/bf02505036 · Cited by 71
Immunological pathomechanisms in vitiligo
Kemp, E. H., Waterman, E. A., & Weetman, A. P. (2001) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399401003362 · Cited by 68
Successful Treatment of Oxidative Stress in Vitiligo
Schallreuter, K. U. (1999) · Skin Pharmacology and Physiology · doi:10.1159/000029867 · Cited by 67
Vitiligo as an inflammatory skin disorder: a therapeutic perspective
Taı̈eb, A. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00939.x · Cited by 65
Vitiligo autoantibodies are effective against melanoma
Fishman, P., Zigelman, R., Floro, S., Djaldetti, M., Azizi, E., Shoenfeld, Y., Sredni, B., Yecheskel, G., Ferrone, S., & Chaitchik, S. (1993) · Cancer · Cited by 63
Central role of defective apoptosis in autoimmunity
Kühtreiber, W. M., Hayashi, T., Dale, E., & Faustman, D. L. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310373 · Cited by 62
Shajil, E. M., Laddha, N. C., Chatterjee, S., et al. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00406.x · Cited by 54
Self-citationLymphocyte imbalance in vitiligo patients indicated by elevated CD4+/CD8+ T-cell ratio
Pichler, R., Sfetsos, K., Badics, B., Gutenbrunner, S., Berg, J., & Auböck, J. (2009) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-009-0699-z · Cited by 52
Superoxide anions, free-radical scavengers, and nitrergic neurotransmission
Gibson, A., & Lilley, E. J. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00281-9 · Cited by 44
Increased oxidative DNA damage in mononuclear leukocytes in vitiligo
Giovannelli, L., Bellandi, S., Pitozzi, V., Fabbri, P., Dolara, P., & Moretti, S. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.07.005 · Cited by 44
Free radical theory of autoimmunity
Kannan, S. (2006) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-3-22 · Cited by 41
Dwivedi, M., Laddha, N. C., Imran, M., Shah, B. J., & Begum, R. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00892.x · Cited by 40
Self-citationDwivedi, M., Laddha, N. C., Shajil, E. M., Shah, B. J., & Begum, R. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00462.x · Cited by 38
Self-citationAssessment of the immune system in 55 Iranian patients with vitiligo
Farrokhi, S., Hojjat‐Farsangi, M., Noohpisheh, M. K., et al. (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2005.01295.x · Cited by 37
Reimann, E., Kingo, K., Karelson, M., Reemann, P., Loite, U., Sulakatko, H., Keermann, M., Raud, K., Abram, K., Vasar, E., et al. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.01.011 · Cited by 36
Association of PTPN22 1858C/T polymorphism with vitiligo susceptibility in Gujarat population
Laddha, N. C., Dwivedi, M., Shajil, E. M., et al. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.10.002 · Cited by 36
Self-citationAssociation of Generalized Vitiligo with MHC Class II Loci in Patients from the Indian Subcontinent
Birlea, S. A., Ahmad, F. J., Mohy‐ud‐Din, R., Ahmad, S., Pal, S. S., Begum, R., Laddha, N. C., Dwivedi, M., Mansuri, M. S., Jin, Y., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.501 · Cited by 36
Self-citationVitiligo Antibodies Are Not Directed to Tyrosinase
Xie, Z., Chen, D., Jiao, D., & Bystryn, J. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.4.417 · Cited by 33
Tetrahydrobiopterin: Basic biochemistry and role in human disease
Saffran, M. (1998) · Biochemical Education · doi:10.1016/s0307-4412(98)00066-1 · Cited by 29
Clemens, M., VENROOIJ, W. J. V., & van de Putte, L. B. A. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400633 · Cited by 29
Tetrahydrobiopterin: Basic Biochemistry and Role in Human Disease
Kaufman, S. (1997) · Medical Entomology and Zoology · Cited by 27
Expression of IL-17 and COX2 gene in peripheral blood leukocytes of vitiligo patients.
Esmaeili, B., Rezaee, S. A., Layegh, P., Afshari, J. T., Dye, P., Karimiani, E. G., Kalalinia, F., & Rafatpanah, H. (2011) · PubMed · Cited by 25
Elassiuty, Y. E., Klarquist, J. S., Speiser, J. J., Youssef, R. M., Al-Refae, A.-E., Hunter, N. S., Shaker, O. G., Gundeti, M. S., Nieuweboer‐Krobotová, L., & Poole, I. C. L. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01232.x · Cited by 18
The Double Strike Hypothesis of the vitiligo pathomechanism: New approaches to vitiligo and melanoma
Michelsen, D. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.08.008 · Cited by 15
Cited by
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
Rahal, A., Kumar, A., Singh, V., Yadav, B., Tiwari, R., Chakraborty, S., & Dhama, K. (2014) · BioMed Research International · doi:10.1155/2014/761264 · Cited by 1,706
New discoveries in the pathogenesis and classification of vitiligo
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.048 · Cited by 476
The use of skin models in drug development
Mathes, S. H., Ruffner, H., & Graf-Hausner, U. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.006 · Cited by 318
Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity
Wang, Y., Li, S., & Li, C. (2019) · Medical Science Monitor · doi:10.12659/msm.914898 · Cited by 176
Demirbaş, A., Elmas, Ö. F., Atasoy, M., Türsen, Ü., & Lotti, T. (2021) · Archives of Dermatological Research · doi:10.1007/s00403-020-02129-3 · Cited by 41
Metadata
- Authors
- Laddha, N. C., Dwivedi, M., Mansuri, M. S., Gani, A. R., Ansarullah, M., Ramachandran, A. V., Dalai, S., & Begum, R.
- Venue
- Experimental Dermatology
- Publisher
- Wiley
- Published
- 2013-02-21
- Volume
- 22
- Issue
- 4
- Pages
- 245-250
- ISSN
- 0906-6705 (ISSN-L)
- 1600-0625
- OpenAlex
- W2117147802
- Cited by
- 273
- References
- 100
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.